GlobeNewsWire
24 Sept 2026, 23:33 UTC · 1h ago
Verdict
Headline takes no side. We score ADRX +0.80 across three claims — strongly bullish.
+0.80strongly bullish
More positive than 87% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish · 3 new · 0 priced in
AbbVie has agreed to a concurrent private placement to own approximately 4.9% of ADARx's outstanding shares at $17.00 per share.
Newpress release dated Sept 24, 2026
So whatStrategic validation from a major pharma player often leads to a valuation premium and reduces the perceived risk of the siRNA pipeline.
More positive than 93% of claims this week
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
ADARx priced its upsized IPO of 26,250,000 shares at $17.00 per share, with gross proceeds of approximately $446.3 million.
Newpress release dated Sept 24, 2026
So whatCombined with the private placement, the company secures $535.2 million in total gross capital to fund late-stage clinical trials.
More positive than 78% of claims this week
ADARx shares are expected to begin trading on the Nasdaq Global Select Market on September 25, 2026, under ticker 'ADRX'.
Newpress release dated Sept 24, 2026
More positive than 43% of claims this week
Which stocks this story touches
More positive than 87% of ticker scores this week
The company is successfully launching an upsized IPO and securing a private placement investment, raising over $535 million.
More positive than 53% of ticker scores this week
The company is strategically expanding its portfolio by investing in a late-stage biotechnology firm.
More positive than 47% of ticker scores this week
Acting as a lead book-running manager for a successful upsized IPO.
More positive than 47% of ticker scores this week
Acting as a lead book-running manager for a successful upsized IPO.
More positive than 47% of ticker scores this week
Acting as a lead book-running manager for a successful upsized IPO.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
—
No price for ADRX right now — the quote feed didn't answer.
ADRX chart →
